Angiogenesis Inhibitor

1 Drug classified under this drug class

Angiogenesis Inhibitor. Pomalidomide 1 mg, 2 mg, 3 mg, 4 mg.
HC 14/20/21/28/30/X 1/2/3/4 mg
4mg X1/d on 1-21 days of 28-days cycles. Dosing to be modif. based on clin. and lab. findings. Discont. upon dis. progress.
 In combin. with bortezomib and dexamethasone for adlt. pts. with multiple myeloma who have received at least one prior tmt. regimen incl. lenalidomide.
In combin. with dexamethasone for adlt. pts. with relapsed and refract. multiple myeloma who have received at least two prior tmt., incl. both lenalidomide and bortezomib, and have demonstr. dis. progress. on the last ther.
C/I: Hypersens. Pregn. Women of childbearing pot. unless on PPP. Male pts. unable to comply with contraception.